Anti-IGF-I receptor antibodies, encoding nucleic acid molecules and methods of using said antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11629194
APP PUB NO 20200115460A1
SERIAL NO

16610396

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides an anti-IGF-I receptor antibody that binds specifically to an IGF-I receptor of a vertebrate and has the proliferation-inducing activity of a vertebrate-derived cell, or a fragment thereof, or derivatives of these.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • TEIJIN PHARMA LIMITED

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Eguchi, Hiroshi Tokyo, JP 92 343
Kato, Hirotsugu Tokyo, JP 16 37
Namiki, Naoko Tokyo, JP 6 6
Takagi, Kenichiro Tokyo, JP 11 23
Tanokura, Akira Tokyo, JP 8 7
Yamamura, Satoshi Tokyo, JP 87 694

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 18, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 18, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 18, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00